1006040-85-2Relevant academic research and scientific papers
AGONISTS OF THE SPHINGOSINE- 1- PHOSPHATE RECEPTOR (SLP)
-
Page/Page column 126, (2008/06/13)
The invention provides compounds of formula I and formula II, their preparation, a their use as pharmaceutically active immunosuppressive agents for the treatment of autoimmune disorders, organ transplant rejection, disorders associated with an activated immune system, as well as other disorders modulated by lymphopenia or SlP receptors.
